Form 8K In8bio Inc For: 19 December
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
In8bio Inc (INAB)
Assess today's live In8bio Inc (INAB) share price, performance and insights using our live NASDAQ: INAB stock exchange data.
Analyse the historical data and In8bio Inc share price performance charts on this page. Our technical summary section provides analysis on In8bio share price buy/sell indicators using real-time data (or discuss the In8bio (INAB) stock price today with other investors in the In8bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ INAB share price (ISIN: US45674E2081) to enhance your trading decisions with our free investment tools and resources.
What Is the In8bio Inc Share Price Today?
The In8bio share price today is 1.750.
What Is the Stock Symbol for In8bio Inc
The stock symbol (or 'ticker') for In8bio Inc is "INAB."
What Stock Exchange Does In8bio Inc Trade On?
In8bio Inc is listed and trades on the NASDAQ stock exchange.
Is In8bio Inc a Good Stock to Buy?
Determining whether In8bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and In8bio Inc share price performance charts on this page. Our technical summary section provides analysis on In8bio share price buy/sell indicators using real-time data (or discuss the In8bio (INAB) stock price today with other investors in the In8bio NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ INAB share price (ISIN: US45674E2081) to enhance your trading decisions with our free investment tools and resources.
What Is the In8bio Inc Share Price Today?
The In8bio share price today is 1.750.
What Is the Stock Symbol for In8bio Inc
The stock symbol (or 'ticker') for In8bio Inc is "INAB."
What Stock Exchange Does In8bio Inc Trade On?
In8bio Inc is listed and trades on the NASDAQ stock exchange.
Is In8bio Inc a Good Stock to Buy?
Determining whether In8bio Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.350
1.790
52 wk Range
1.170
12.531
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3501.790
52 wk Range
1.17012.531
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
INAB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
46.900
Upside
+2,580.00%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
In8bio Company Profile
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product candidate, which is in Phase I clinical trial to treat patients with hematologic malignancies undergoing hematopoietic stem cell transplantation. The company also develops INB-619, a gamma-delta TCE targeting CD19 for both oncology and autoimmune diseases; INB-300, a nsCAR-enabled DeltEx product candidates targeting difficult liquid tumors and extracranial solid tumors; and INB-500, an induced pluripotent stem cell derived gamma-delta T cells that are in preclinical phase for treatment of cancer. The company was formerly known as Incysus Therapeutics, Inc. and changed its name to IN8bio, Inc. in August 2020. IN8bio, Inc. was incorporated in 2016 and is based in New York, New York.
Compare INAB to Peers and Sector
Metrics to compare | INAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipINABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −3.2x | −0.6x | |
PEG Ratio | 0.00 | 0.09 | 0.00 | |
Price/Book | 0.6x | 4.4x | 2.6x | |
Price / LTM Sales | - | 201.0x | 3.2x | |
Upside (Analyst Target) | - | 235.0% | 41.8% | |
Fair Value Upside | Unlock | −7.3% | 5.1% | Unlock |
Analyst Ratings
4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 46.900
(+2,580.00% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
-0.85 / -0.05
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the In8bio (INAB) Share Price Today?
The live In8bio share price today is 1.750
What Stock Exchange Does In8bio (INAB) Trade On?
In8bio is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for In8bio?
The stock symbol (also called a 'ticker') for In8bio is "INAB."
What Is the Current In8bio Market Cap?
As of today, In8bio market capitalisation is 8.02M.
What Is In8bio's (INAB) Earnings Per Share (TTM)?
The In8bio EPS is currently -6.36 (Trailing Twelve Months).
Is INAB a Buy or Sell From a Technical Analyst Perspective?
Based on today's In8bio moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has In8bio Stock Split?
In8bio has split 1 times. (See the INAB stock split history page for full effective split date and price information.)
How Many Employees Does In8bio Have?
In8bio has 17 employees.
What is the current trading status of In8bio (INAB)?
As of 24 Dec 2025, In8bio (INAB) is trading at a price of 1.750, with a previous close of 1.550. The stock has fluctuated within a day range of 1.350 to 1.790, while its 52-week range spans from 1.170 to 12.531.
What Is In8bio (INAB) Price Target According to Analysts?
The average 12-month price target for In8bio is USD46.90004, with a high estimate of USD180.00018 and a low estimate of USD3. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +2,580.00% Upside potential.
What Is the INAB Premarket Price?
INAB's last pre-market stock price is 1.510. The pre-market share volume is 15,530.000, and the stock has decreased by -0.040, or -2.580%.
What Is the INAB After Hours Price?
INAB's last after hours stock price is 1.780, the stock has decreased by 0.030, or 1.710%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.